FDA outside experts face stricter rules on industry ties

08/4/2008 | Hill, The

The FDA announced that it will not let outside experts serve on an advisory panel if they or their immediate relatives have a financial stake of $50,000 or more in a drug or medical-device firm being reviewed. The restriction is part of the agency's new policies that address concerns about its independent advisers' industry relationships, including objectivity and conflicts of interest.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ